Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Prevalence of Non-B HIV-1 Subtypes in North Italy and Analysis of Transmission Clusters Based on Sequence Data Analysis.

Lorenzin G, Gargiulo F, Caruso A, Caccuri F, Focà E, Celotti A, Quiros-Roldan E, Izzo I, Castelli F, De Francesco MA.

Microorganisms. 2019 Dec 23;8(1). pii: E36. doi: 10.3390/microorganisms8010036.

2.

Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.

Dickinson L, Gurjar R, Stöhr W, Bonora S, Owen A, D'Avolio A, Cursley A, Molina JM, Fäetkenheuer G, Vandekerckhove L, Di Perri G, Pozniak A, Richert L, Raffi F, Boffito M; NEAT001/ANRS143 Study Group .

J Antimicrob Chemother. 2019 Nov 21. pii: dkz479. doi: 10.1093/jac/dkz479. [Epub ahead of print]

PMID:
31754703
3.

Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort.

Focà E, Magro P, Guaraldi G, Riva A, Cattelan AM, De Socio GV, Costa C, Piconi S, Celesia BM, Nozza S, Orofino G, Castagna A, Di Perri G, Castelli F, Calcagno A; GEPPO (GEriatric Patients living with HIV/AIDS: a Prospective Multidimensional cOhort) Study Group.

PLoS One. 2019 Oct 17;14(10):e0222225. doi: 10.1371/journal.pone.0222225. eCollection 2019.

4.

Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances.

Lapadula G, Bernasconi DP, Bai F, Focà E, Di Biagio A, Bonora S, Castelli F, Squillace N, Bandera A, Monforte AD, Migliorino GM, Gori A; SWEAR Study Group.

AIDS. 2020 Jan 1;34(1):53-61. doi: 10.1097/QAD.0000000000002377.

PMID:
31567160
5.

A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study).

Mussini C, Roncaglia E, Borghi V, Rusconi S, Nozza S, Cattelan AM, Segala D, Bonfanti P, Di Biagio A, Barchi E, Focà E, Degli Antoni A, Bonora S, Francisci D, Limonta S, Antinori A, D'Ettorre G, Maggiolo F.

PLoS One. 2019 Sep 27;14(9):e0222650. doi: 10.1371/journal.pone.0222650. eCollection 2019.

6.

Disengagement and reengagement of HIV continuum of care in a single center cohort in northern Italy.

Comelli A, Izzo I, Donato F, Celotti A, Focà E, Pezzoli C, Castelli F, Quiros-Roldan E.

HIV Res Clin Pract. 2019 Feb;20(1):1-11. doi: 10.1080/15284336.2019.1595887. Epub 2019 Apr 25.

PMID:
31303148
7.

Impact of genotypic susceptibility score on cART outcomes during primary HIV infection.

Giacomelli A, Fabbiani M, De Benedetto I, Nozza S, Focà E, Celesia BM, Marchetti G, Mussini C, Antinori A, d'Ettorre G, Madeddu G, Bandera A, Muscatello A, Rusconi S.

J Med Virol. 2019 Oct;91(10):1891-1895. doi: 10.1002/jmv.25517. Epub 2019 Jun 27.

PMID:
31199538
8.

Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease.

Pinzone MR, Ceccarelli M, Venanzi Rullo E, Maresca M, Bruno R, Condorelli F, Di Rosa M, Madeddu G, Focà E, Calcagno A, Celesia BM, Cacopardo B, Nunnari G, Pellicanò GF.

Biomed Rep. 2019 Feb;10(2):140-144. doi: 10.3892/br.2019.1183. Epub 2019 Jan 7.

9.

Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions?

Trunfio M, Pinnetti C, Focà E, Bai F, Maffongelli G, Celani L, Cinque P, Celotti A, Andreoni M, D'Arminio Monforte A, D'Ettorre G, Antinori A, Calcagno A.

AIDS. 2019 Mar 15;33(4):759-762. doi: 10.1097/QAD.0000000000002091.

PMID:
30531317
10.

Prognostic role of inflammatory biomarkers in HIV-infected patients with a first diagnosis of hepatocellular carcinoma: A single-center study.

Quiros-Roldan E, Properzi M, Amadasi S, Raffetti E, Ferraresi A, Biasi L, Focà E, Castelli F.

J Med Virol. 2019 Feb;91(2):241-248. doi: 10.1002/jmv.25317. Epub 2018 Oct 31.

PMID:
30216474
11.

Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature.

Zanotti P, Chirico C, Gulletta M, Ardighieri L, Casari S, Roldan EQ, Izzo I, Pinsi G, Lorenzin G, Facchetti F, Castelli F, Focà E.

Mediterr J Hematol Infect Dis. 2018 Jul 1;10(1):e2018040. doi: 10.4084/MJHID.2018.040. eCollection 2018. Review.

12.

Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-Ritonavir.

Focà E, Calcagno A, Bonito A, Cusato J, Domenighini E, D'Avolio A, Quiros Roldan E, Trentini L, Castelnuovo F, Di Perri G, Castelli F, Bonora S.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00309-18. doi: 10.1128/AAC.00309-18. Print 2018 Jul.

13.

Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial.

Fabbiani M, Gagliardini R, Ciccarelli N, Quiros Roldan E, Latini A, d'Ettorre G, Antinori A, Castagna A, Orofino G, Francisci D, Chinello P, Madeddu G, Grima P, Rusconi S, Del Pin B, Lombardi F, D'Avino A, Focà E, Colafigli M, Cauda R, Di Giambenedetto S, De Luca A; ATLAS-M Study Group.

J Antimicrob Chemother. 2018 Jul 1;73(7):1955-1964. doi: 10.1093/jac/dky123.

PMID:
29668978
14.

Prevalence of Integrase Strand Transfer Inhibitors Resistance Mutations in Integrase Strand Transfer Inhibitors-Naive and -Experienced HIV-1 Infected Patients: A Single Center Experience.

De Francesco MA, Izzo I, Properzi M, Gargiulo F, Caccuri F, Quiros-Roldan E, Castelli F, Caruso A, Focà E.

AIDS Res Hum Retroviruses. 2018 Jul;34(7):570-574. doi: 10.1089/AID.2018.0006. Epub 2018 May 9.

PMID:
29631420
15.

The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia.

Quiros-Roldan E, Castelli F, Lanza P, Pezzoli C, Vezzoli M; Inflammation in HIV Study Group, Biasiotto G, Zanella I.

J Transl Med. 2017 Dec 19;15(1):256. doi: 10.1186/s12967-017-1358-6.

16.

Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians.

Palummieri A, De Carli G, Rosenthal É, Cacoub P, Mussini C, Puro V; PrEPventHIV Italy Study Group.

BMC Infect Dis. 2017 Nov 28;17(1):734. doi: 10.1186/s12879-017-2819-5.

17.

Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy).

Izzo I, Casari S, Bossini N, Forleo MA, Sandrini S, Focà E, Brianese N, Zambolin G, Chirico C, Cancarini G, Castelli F.

Infection. 2018 Feb;46(1):77-82. doi: 10.1007/s15010-017-1092-2. Epub 2017 Nov 4.

PMID:
29103079
18.

Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study.

Nozza S, Malagoli A, Maia L, Calcagno A, Focà E, De Socio G, Piconi S, Orofino G, Cattelan AM, Celesia BM, Gervasi E, Guaraldi G; GEPPO Study Group.

J Antimicrob Chemother. 2017 Oct 1;72(10):2961. doi: 10.1093/jac/dkx282. No abstract available.

PMID:
29091220
19.

Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus.

Castagna A, Ferrara M, Galli L, Comi L, Sterrantino G, Cenderello G, Zaccarelli M, Focà E, Roncadori A, Lazzarin A; PRESTIGIO Study Group.

J Antimicrob Chemother. 2018 Jan 1;73(1):177-182. doi: 10.1093/jac/dkx371.

PMID:
29077927
20.

Perinatally HIV-Infected Youths After Transition from Pediatric to Adult Care, a Single-Center Experience from Northern Italy.

Izzo I, Quiros-Roldan E, Saccani B, Chiari E, Casari S, Focà E, Pezzoli MC, Forleo MA, Bonito A, Badolato R, Dotta L, Castelli F.

AIDS Res Hum Retroviruses. 2018 Mar;34(3):241-243. doi: 10.1089/AID.2017.0120. Epub 2017 Nov 17.

PMID:
29061072

Supplemental Content

Loading ...
Support Center